MESNEX (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the MESNEX drug offered from Baxter Healthcare Corporation. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: mesna
SUBSTANCE NAME: MESNA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1988-12-30
END MARKETING DATE: 0000-00-00


MESNEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMESNEX from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 1988-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-1305_22dd9d12-b425-454f-9835-a0807595acdd
PRODUCT NDC: 0338-1305
APPLICATION NUMBER: NDA019884

Other MESNA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationMESNEX
Fresenius Kabi USA, LLCMesna
Mylan Institutional LLCMesna
Sagent PharmaceuticalsMesna
Teva Parenteral Medicines, Inc.Mesna